Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q37839049
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241120235906.0 |
008
|
|
|
241120nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q37839049
|
024
|
|
|
‡a
0000-0001-7275-6462
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q37839049
|
100
|
0 |
|
‡a
Miguel Ángel Medina
‡c
researcher
‡9
en
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Miguel Ángel Medina
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Miguel Ángel Medina
‡c
investigador
‡9
ast
|
400
|
0 |
|
‡a
Miguel Ángel Medina
‡c
ricercatore
‡9
it
|
400
|
0 |
|
‡a
Miguel Ángel Medina
‡c
investigador
‡9
es
|
670
|
|
|
‡a
Author's (+)-Aeroplysinin-1 Modulates the Redox Balance of Endothelial Cells
|
670
|
|
|
‡a
Author's 4-methylumbelliferone inhibits angiogenesis in vitro and in vivo
|
670
|
|
|
‡a
Author's 5. Synthesis, metabolism and release of histamine
|
670
|
|
|
‡a
Author's A combined model of hepatic polyamine and sulfur amino acid metabolism to analyze S-adenosyl methionine availability
|
670
|
|
|
‡a
Author's A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation.
|
670
|
|
|
‡a
Author's A novel homogenous assay for topoisomerase II action and inhibition
|
670
|
|
|
‡a
Author's A plasma membrane redox system in human retinoblastoma cells
|
670
|
|
|
‡a
Author's A problem-/case-based learning approach as an useful tool for studying glycogen metabolism and its regulation
|
670
|
|
|
‡a
Author's A re-evaluation of fumagillin selectivity towards endothelial cells
|
670
|
|
|
‡a
Author's A re-evaluation of the mitogenic effect of serotonin on vascular endothelial cells
|
670
|
|
|
‡a
Author's Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment
|
670
|
|
|
‡a
Author's Altered ornithine metabolism in tumor-bearing mice
|
670
|
|
|
‡a
Author's An experiment on apoptosis induced by polyamine adducts produced in the presence of serum amine oxidase
|
670
|
|
|
‡a
Author's An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion.
|
670
|
|
|
‡a
Author's Analysis of Mammalian Histidine Decarboxylase Dimerization Interface Reveals an Electrostatic Hotspot Important for Catalytic Site Topology and Function
|
670
|
|
|
‡a
Author's Anti-angiogenic effects of homocysteine on cultured endothelial cells
|
670
|
|
|
‡a
Author's Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary.
|
670
|
|
|
‡a
Author's Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge
|
670
|
|
|
‡a
Author's Ascorbic acid is cytotoxic for pediatric tumor cells cultured in vitro
|
670
|
|
|
‡a
Author's Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications
|
670
|
|
|
‡a
Author's Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
|
670
|
|
|
‡a
Author's Characterization of plasma membrane redox activity from Ehrlich cells
|
670
|
|
|
‡a
Author's Characterization of spermine uptake by Ehrlich tumour cells in culture.
|
670
|
|
|
‡a
Author's Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines
|
670
|
|
|
‡a
Author's Comparison of the anti-angiogenic potential of hydroxytyrosol and five derivatives
|
670
|
|
|
‡a
Author's Contribution by host tissues to circulating glutamine in mice inoculated with Ehrlich ascites tumor cells
|
670
|
|
|
‡a
Author's Correction: Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene.
|
670
|
|
|
‡a
Author's Correction: Global Analysis of the Human Pathophenotypic Similarity Gene Network Merges Disease Module Components
|
670
|
|
|
‡a
Author's Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells
|
670
|
|
|
‡a
Author's Damnacanthal inhibits IgE receptor-mediated activation of mast cells
|
670
|
|
|
‡a
Author's Danthron, an Anthraquinone Isolated from a Marine Fungus, Is a New Inhibitor of Angiogenesis Exhibiting Interesting Antitumor and Antioxidant Properties
|
670
|
|
|
‡a
Author's Determination of a cAMP-dependent protein kinase phosphorylation site in the C-terminal region of human endothelial actin-binding protein
|
670
|
|
|
‡a
Author's Development of an expression macroarray for amine metabolism-related genes.
|
670
|
|
|
‡a
Author's Diamines interfere with the transport of L-ornithine in Ehrlich-cell plasma-membrane vesicles
|
670
|
|
|
‡a
Author's Dietary proteins and angiogenesis
|
670
|
|
|
‡a
Author's Dimethylfumarate inhibits angiogenesis in vitro and in vivo: a possible role for its antipsoriatic effect?
|
670
|
|
|
‡a
Author's DNA-chlorpheniramine interaction studied by spectroscopic techniques.
|
670
|
|
|
‡a
Author's Do not say ever never more: the ins and outs of antiangiogenic therapies
|
670
|
|
|
‡a
Author's DTD, an anti-inflammatory ditriazine, inhibits angiogenesis in vitro and in vivo
|
670
|
|
|
‡a
Author's Dual role of plasma membrane electron transport systems in defense
|
670
|
|
|
‡a
Author's Early systemic effects on the hepatic mitochondria of tumour bearing mice
|
670
|
|
|
‡a
Author's Effect of palmitate, acetate and glucose on glutamine metabolism in Ehrlich ascites tumor cells
|
670
|
|
|
‡a
Author's Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells
|
670
|
|
|
‡a
Author's Effects of phorbol ester and dexamethasone treatment on histidine decarboxylase and ornithine decarboxylase in basophilic cells
|
670
|
|
|
‡a
Author's Effects of protein kinase C and phosphoprotein phosphatase modulators on Ehrlich cell plasma membrane redox system activity
|
670
|
|
|
‡a
Author's Effects of ursolic acid on different steps of the angiogenic process
|
670
|
|
|
‡a
Author's Ehrlich cell plasma membrane redox system is modulated through signal transduction pathways involving cGMP and Ca2+ as second messengers
|
670
|
|
|
‡a
Author's (-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes.
|
670
|
|
|
‡a
Author's Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro
|
670
|
|
|
‡a
Author's ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes.
|
670
|
|
|
‡a
Author's Evaluation of the anti-angiogenic effect of aloe-emodin
|
670
|
|
|
‡a
Author's Evidence of an intracellular dissipative structure
|
670
|
|
|
‡a
Author's Experimental evidence for structure-activity features in common between mammalian histidine decarboxylase and ornithine decarboxylase
|
670
|
|
|
‡a
Author's Exploring and challenging the network of angiogenesis.
|
670
|
|
|
‡a
Author's Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner
|
670
|
|
|
‡a
Author's First steps in computational systems biology: A practical session in metabolic modeling and simulation.
|
670
|
|
|
‡a
Author's Fourier transform Raman study of the structural specificities on the interaction between DNA and biogenic polyamines
|
670
|
|
|
‡a
Author's Functional reconstitution of Ehrlich cell plasma membrane ferricyanide reductase
|
670
|
|
|
‡a
Author's Genetic basis of hyperhomocysteinemia.
|
670
|
|
|
‡a
Author's Glucose Favors Lipid Anabolic Metabolism in the Invasive Breast Cancer Cell Line MDA-MB-231
|
670
|
|
|
‡a
Author's Glutamine and glucose as energy substrates for Ehrlich ascites tumour cells
|
670
|
|
|
‡a
Author's Glutamine transport by vesicles isolated from tumour-cell mitochondrial inner membrane
|
670
|
|
|
‡a
Author's Glycolysis and glutaminolysis in perifused Ehrlich ascites tumour cells
|
670
|
|
|
‡a
Author's Green tea epigallocatechin-3-gallate is an inhibitor of mammalian histidine decarboxylase
|
670
|
|
|
‡a
Author's Histamine, polyamines, and cancer.
|
670
|
|
|
‡a
Author's Homocysteine: an emergent cardiovascular risk factor?
|
670
|
|
|
‡a
Author's Homocysteine inhibits the proliferation and invasive potential of HT-1080 human fibrosarcoma cells
|
670
|
|
|
‡a
Author's Homocysteine is a potent inhibitor of human tumor cell gelatinases
|
670
|
|
|
‡a
Author's Homocysteine is a potent modulator of plasma membrane electron transport systems.
|
670
|
|
|
‡a
Author's Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process
|
670
|
|
|
‡a
Author's Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.
|
670
|
|
|
‡a
Author's Hypericin in the dark inhibits key steps of angiogenesis in vitro
|
670
|
|
|
‡a
Author's IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo
|
670
|
|
|
‡a
Author's Identification of a Zn
|
670
|
|
|
‡a
Author's Identification of a Zn(2+)-sensitive component of Ehrlich cell plasma membrane redox system by CHAPS-agarose-polyacrylamide electrophoresis and in situ staining of activity
|
670
|
|
|
‡a
Author's In silico analysis of arginine catabolism as a source of nitric oxide or polyamines in endothelial cells.
|
670
|
|
|
‡a
Author's In vitro study of proteolytic degradation of rat histidine decarboxylase
|
670
|
|
|
‡a
Author's Inorganic phosphate and energy charge compartmentation in Ehrlich ascites tumour cells in the presence of glucose and/or glutamine
|
670
|
|
|
‡a
Author's Insights on the antitumor effects of kahweol on human breast cancer: decreased survival and increased production of reactive oxygen species and cytotoxicity
|
670
|
|
|
‡a
Author's Interchange of amino acids between tumor and host
|
670
|
|
|
‡a
Author's Involvement of essential histidine residue
|
670
|
|
|
‡a
Author's Involvement of essential histidine residue(s) in the activity of Ehrlich cell plasma membrane NADH-ferricyanide oxidoreductase
|
670
|
|
|
‡a
Author's kpath: integration of metabolic pathway linked data
|
670
|
|
|
‡a
Author's L-alanine transport by systems A and ASC in plasma membrane vesicles isolated from Ehrlich cells
|
670
|
|
|
‡a
Author's L-glutamine transport in native vesicles isolated from Ehrlich ascites tumor cell membranes.
|
670
|
|
|
‡a
Author's Local changes in the catalytic site of mammalian histidine decarboxylase can affect its global conformation and stability
|
670
|
|
|
‡a
Author's Malate-citrate cycle during glycolysis and glutaminolysis in Ehrlich ascites tumor cells
|
670
|
|
|
‡a
Author's Mathematical modeling of polyamine metabolism in mammals.
|
670
|
|
|
‡a
Author's Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity
|
670
|
|
|
‡a
Author's Metabolic Reprogramming is a Hallmark of Metabolism Itself
|
670
|
|
|
‡a
Author's Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target
|
670
|
|
|
‡a
Author's Methods for the determination of plasma total homocysteine: a review.
|
670
|
|
|
‡a
Author's Mitoxantrone toxicity on Ehrlich ascites tumour cells: inhibition of the transplasma membrane redox activity.
|
670
|
|
|
‡a
Author's Mobilization of glutamine and asparagine in mouse kidney during Ehrlich cell carcinoma development
|
670
|
|
|
‡a
Author's Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein
|
670
|
|
|
‡a
Author's Monocyte chemoattractant protein-1: a key mediator in inflammatory processes.
|
670
|
|
|
‡a
Author's Multifunctional plasma membrane redox systems
|
670
|
|
|
‡a
Author's Mutual effect of glucose and glutamine on their utilization by tumour cells
|
670
|
|
|
‡a
Author's Na(+)-dependent AIB transport by neuroblastoma cells
|
670
|
|
|
‡a
Author's Nitrogen metabolism in tumor bearing mice
|
670
|
|
|
‡a
Author's On the interpretation of Raman spectra of 1-aminooxy-spermine/DNA complexes.
|
670
|
|
|
‡a
Author's Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.
|
670
|
|
|
‡a
Author's PhenUMA: a tool for integrating the biomedical relationships among genes and diseases.
|
670
|
|
|
‡a
Author's Phosphate-activated glutaminase expression during tumor development.
|
670
|
|
|
‡a
Author's Plasma membrane redox activity correlates with N-myc expression in neuroblastoma cells
|
670
|
|
|
‡a
Author's Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer.
|
670
|
|
|
‡a
Author's Pleiotropic Role of Puupehenones in Biomedical Research.
|
670
|
|
|
‡a
Author's Polyamine contents of human breast cancer cells treated with the cytotoxic agents chlorpheniramine and dehydrodidemnin B
|
670
|
|
|
‡a
Author's Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells.
|
670
|
|
|
‡a
Author's Polyamine metabolism revisited
|
670
|
|
|
‡a
Author's Polyamines in mammalian pathophysiology
|
670
|
|
|
‡a
Author's Polyamines: metabolism to systems biology and beyond.
|
670
|
|
|
‡a
Author's Prognostic value of serum angiogenic activity in colorectal cancer patients.
|
670
|
|
|
‡a
Author's Protopia: a protein-protein interaction tool
|
670
|
|
|
‡a
Author's Purification and characterization of a plasma membrane ferricyanide-utilizing NADH dehydrogenase from Ehrlich tumour cells
|
670
|
|
|
‡a
Author's Purification of phosphate-dependent glutaminase from isolated mitochondria of Ehrlich ascites-tumour cells.
|
670
|
|
|
‡a
Author's Putrescine and chlorpheniramine inhibit Ehrlich ascites tumor cell plasma membrane ferricyanide reductase activity
|
670
|
|
|
‡a
Author's Raman spectroscopy study of the interaction between biogenic polyamines and an alternating AT oligodeoxyribonucleotide
|
670
|
|
|
‡a
Author's Raman study of the interaction between polyamines and a GC oligonucleotide
|
670
|
|
|
‡a
Author's Rat histidine decarboxylase is a substrate for m-calpain in vitro
|
670
|
|
|
‡a
Author's Real-time RT-PCR analysis of human histidine decarboxylase, a new marker for several types of leukemia and cancer.
|
670
|
|
|
‡a
Author's Regulatory cross-talk of mouse liver polyamine and methionine metabolic pathways: a systemic approach to its physiopathological consequences.
|
670
|
|
|
‡a
Author's Relevance of glutamine metabolism to tumor cell growth
|
670
|
|
|
‡a
Author's Roles of homocysteine in cell metabolism: old and new functions.
|
670
|
|
|
‡a
Author's Short-term effect of glutamine on the incorporation of glucose-carbon into nucleic acids in Ehrlich ascites tumour cells
|
670
|
|
|
‡a
Author's Social pathway annotation: extensions of the systems biology metabolic modelling assistant
|
670
|
|
|
‡a
Author's Sodium-dependent L-serine transport in plasma membrane vesicles isolated from Ehrlich cells by two-phase compartmentation
|
670
|
|
|
‡a
Author's Spectroscopic analysis of recombinant rat histidine decarboxylase
|
670
|
|
|
‡a
Author's Structural perspective on the direct inhibition mechanism of EGCG on mammalian histidine decarboxylase and DOPA decarboxylase
|
670
|
|
|
‡a
Author's Study of puupehenone and related compounds as inhibitors of angiogenesis
|
670
|
|
|
‡a
Author's Subcellular distribution of adenine nucleotides in two Ehrlich cell lines metabolizing glucose
|
670
|
|
|
‡a
Author's Synthesis and antiangiogenic activity of new silybin galloyl esters
|
670
|
|
|
‡a
Author's Synthesis and Antitumor Activity Evaluation of Compounds Based on Toluquinol
|
670
|
|
|
‡a
Author's Systems biology for molecular life sciences and its impact in biomedicine
|
670
|
|
|
‡a
Author's Systems biology metabolic modeling assistant: an ontology-based tool for the integration of metabolic data in kinetic modeling.
|
670
|
|
|
‡a
Author's The anti-angiogenic 8-epipuupehedione behaves as a potential anti-leukaemic compound against HL-60 cells
|
670
|
|
|
‡a
Author's The antiangiogenic compound aeroplysinin-1 induces apoptosis in endothelial cells by activating the mitochondrial pathway.
|
670
|
|
|
‡a
Author's The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cells
|
670
|
|
|
‡a
Author's The marine fungal metabolite, AD0157, inhibits angiogenesis by targeting the Akt signaling pathway
|
670
|
|
|
‡a
Author's The Mediterranean Diet, a Rich Source of Angiopreventive Compounds in Cancer
|
670
|
|
|
‡a
Author's The noni anthraquinone damnacanthal is a multi-kinase inhibitor with potent anti-angiogenic effects
|
670
|
|
|
‡a
Author's The pest regions containing C-termini of mammalian ornithine decarboxylase and histidine decarboxylase play different roles in protein degradation
|
670
|
|
|
‡a
Author's The pursuit of creativity in biology
|
670
|
|
|
‡a
Author's The role of fructose 2,6-bisphosphate in glycolytic oscillations in extracts and cells of Saccharomyces cerevisiae
|
670
|
|
|
‡a
Author's The StarD4 subfamily of steroidogenic acute regulatory-related lipid transfer
|
670
|
|
|
‡a
Author's The StarD4 subfamily of steroidogenic acute regulatory-related lipid transfer (START) domain proteins: new players in cholesterol metabolism
|
670
|
|
|
‡a
Author's The usefulness of post-genomics tools for characterization of the amine cross-talk in mammalian cells.
|
670
|
|
|
‡a
Author's Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes with the Akt pathway.
|
670
|
|
|
‡a
Author's Topology, tinkering and evolution of the human transcription factor network.
|
670
|
|
|
‡a
Author's Transmembrane ferricyanide reductase activity in Ehrlich ascites tumor cells
|
670
|
|
|
‡a
Author's Two phases of ferricyanide reductase activity in Ehrlich cell plasma membranes
|
670
|
|
|
‡a
Author's What is known on angiogenesis-related rare diseases? A systematic review of literature.
|
670
|
|
|
‡a
Author's When metabolism meets topology: Reconciling metabolite and reaction networks.
|
909
|
|
|
‡a
(orcid) 0000000172756462
‡9
1
|
919
|
|
|
‡a
malatecitratecycleduringglycolysisandglutaminolysisinehrlichascitestumorcells
‡A
Malate-citrate cycle during glycolysis and glutaminolysis in Ehrlich ascites tumor cells
‡9
1
|
919
|
|
|
‡a
mathematicalmodelingofpolyaminemetabolisminmammals
‡A
Mathematical modeling of polyamine metabolism in mammals.
‡9
1
|
919
|
|
|
‡a
matrixmetalloproteinase2andtissueinhibitorofmetalloproteinase2expressioninpaediatrictumourcellseffectsoftumourcellproliferationmodulatorsongelatinolyticactivity
‡A
Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity
‡9
1
|
919
|
|
|
‡a
metabolicreprogrammingisahallmarkofmetabolismitself
‡A
Metabolic Reprogramming is a Hallmark of Metabolism Itself
‡9
1
|
919
|
|
|
‡a
metabolismwithinthetumormicroenvironmentanditsimplicationoncancerprogressionanongoingtherapeutictarget
‡A
Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target
‡9
1
|
919
|
|
|
‡a
methodsforthedeterminationofplasmatotalhomocysteineareview
‡A
Methods for the determination of plasma total homocysteine: a review.
‡9
1
|
919
|
|
|
‡a
mitoxantronetoxicityonehrlichascitestumourcellsinhibitionofthetransplasmamembraneredoxactivity
‡A
Mitoxantrone toxicity on Ehrlich ascites tumour cells: inhibition of the transplasma membrane redox activity.
‡9
1
|
919
|
|
|
‡a
mobilizationofglutamineandasparagineinmousekidneyduringehrlichcellcarcinomadevelopment
‡A
Mobilization of glutamine and asparagine in mouse kidney during Ehrlich cell carcinoma development
‡9
1
|
919
|
|
|
‡a
modulationoftheproteolyticbalanceplasminogenactivatorplasminogenactivatorinhibitorbyenhancednmyconcogeneexpressionorapplicationofgenistein
‡A
Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein
‡9
1
|
919
|
|
|
‡a
monocytechemoattractantprotein1akeymediatorininflammatoryprocesses
‡A
Monocyte chemoattractant protein-1: a key mediator in inflammatory processes.
‡9
1
|
919
|
|
|
‡a
multifunctionalplasmamembraneredoxsystems
‡A
Multifunctional plasma membrane redox systems
‡9
1
|
919
|
|
|
‡a
mutualeffectofglucoseandglutamineontheirutilizationbytumourcells
‡A
Mutual effect of glucose and glutamine on their utilization by tumour cells
‡9
1
|
919
|
|
|
‡a
na+dependentaibtransportbyneuroblastomacells
‡A
Na(+)-dependent AIB transport by neuroblastoma cells
‡9
1
|
919
|
|
|
‡a
nitrogenmetabolismintumorbearingmice
‡A
Nitrogen metabolism in tumor bearing mice
‡9
1
|
919
|
|
|
‡a
ontheinterpretationoframanspectraof1aminooxysperminednacomplexes
‡A
On the interpretation of Raman spectra of 1-aminooxy-spermine/DNA complexes.
‡9
1
|
919
|
|
|
‡a
pharmacologicalpotentialofbiogenicaminepolyamineinteractionsbeyondneurotransmission
‡A
Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.
‡9
1
|
919
|
|
|
‡a
phenumaatoolforintegratingthebiomedicalrelationshipsamonggenesanddiseases
‡A
PhenUMA: a tool for integrating the biomedical relationships among genes and diseases.
‡9
1
|
919
|
|
|
‡a
phosphateactivatedglutaminaseexpressionduringtumordevelopment
‡A
Phosphate-activated glutaminase expression during tumor development.
‡9
1
|
919
|
|
|
‡a
plasmamembraneredoxactivitycorrelateswithnmycexpressioninneuroblastomacells
‡A
Plasma membrane redox activity correlates with N-myc expression in neuroblastoma cells
‡9
1
|
919
|
|
|
‡a
playingonly1instrumentmaybenotenoughlimitationsandfutureoftheantiangiogenictreatmentofcancer
‡A
Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer.
‡9
1
|
919
|
|
|
‡a
pleiotropicroleofpuupehenonesinbiomedicalresearch
‡A
Pleiotropic Role of Puupehenones in Biomedical Research.
‡9
1
|
919
|
|
|
‡a
polyaminecontentsofhumanbreastcancercellstreatedwiththecytotoxicagentschlorpheniramineanddehydrodidemninb
‡A
Polyamine contents of human breast cancer cells treated with the cytotoxic agents chlorpheniramine and dehydrodidemnin B
‡9
1
|
919
|
|
|
‡a
polyaminemetabolismissensitivetoglycolysisinhibitioninhumanneuroblastomacells
‡A
Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells.
‡9
1
|
919
|
|
|
‡a
polyaminemetabolismrevisited
‡A
Polyamine metabolism revisited
‡9
1
|
919
|
|
|
‡a
polyaminesinmammalianpathophysiology
‡A
Polyamines in mammalian pathophysiology
‡9
1
|
919
|
|
|
‡a
polyaminesmetabolismtosystemsbiologyandbeyond
‡A
Polyamines: metabolism to systems biology and beyond.
‡9
1
|
919
|
|
|
‡a
prognosticvalueofserumangiogenicactivityincolorectalcancerpatients
‡A
Prognostic value of serum angiogenic activity in colorectal cancer patients.
‡9
1
|
919
|
|
|
‡a
protopiaaproteinproteininteractiontool
‡A
Protopia: a protein-protein interaction tool
‡9
1
|
919
|
|
|
‡a
purificationandcharacterizationofaplasmamembraneferricyanideutilizingnadhdehydrogenasefromehrlichtumourcells
‡A
Purification and characterization of a plasma membrane ferricyanide-utilizing NADH dehydrogenase from Ehrlich tumour cells
‡9
1
|
919
|
|
|
‡a
purificationofphosphatedependentglutaminasefromisolatedmitochondriaofehrlichascitestumourcells
‡A
Purification of phosphate-dependent glutaminase from isolated mitochondria of Ehrlich ascites-tumour cells.
‡9
1
|
919
|
|
|
‡a
putrescineandchlorpheniramineinhibitehrlichascitestumorcellplasmamembraneferricyanidereductaseactivity
‡A
Putrescine and chlorpheniramine inhibit Ehrlich ascites tumor cell plasma membrane ferricyanide reductase activity
‡9
1
|
919
|
|
|
‡a
ramanspectroscopystudyoftheinteractionbetweenbiogenicpolyaminesandanalternatingatoligodeoxyribonucleotide
‡A
Raman spectroscopy study of the interaction between biogenic polyamines and an alternating AT oligodeoxyribonucleotide
‡9
1
|
919
|
|
|
‡a
ramanstudyoftheinteractionbetweenpolyaminesandagcoligonucleotide
‡A
Raman study of the interaction between polyamines and a GC oligonucleotide
‡9
1
|
919
|
|
|
‡a
rathistidinedecarboxylaseisasubstratefor1000calpaininvitro
‡A
Rat histidine decarboxylase is a substrate for m-calpain in vitro
‡9
1
|
919
|
|
|
‡a
realtimertpcranalysisofhumanhistidinedecarboxylaseanewmarkerforseveraltypesofleukemiaandcancer
‡A
Real-time RT-PCR analysis of human histidine decarboxylase, a new marker for several types of leukemia and cancer.
‡9
1
|
919
|
|
|
‡a
regulatorycrosstalkofmouseliverpolyamineandmethioninemetabolicpathwaysasystemicapproachtoitsphysiopathologicalconsequences
‡A
Regulatory cross-talk of mouse liver polyamine and methionine metabolic pathways: a systemic approach to its physiopathological consequences.
‡9
1
|
919
|
|
|
‡a
relevanceofglutaminemetabolismtotumorcellgrowth
‡A
Relevance of glutamine metabolism to tumor cell growth
‡9
1
|
919
|
|
|
‡a
rolesofhomocysteineincellmetabolismoldandnewfunctions
‡A
Roles of homocysteine in cell metabolism: old and new functions.
‡9
1
|
919
|
|
|
‡a
shorttermeffectofglutamineontheincorporationofglucosecarbonintonucleicacidsinehrlichascitestumourcells
‡A
Short-term effect of glutamine on the incorporation of glucose-carbon into nucleic acids in Ehrlich ascites tumour cells
‡9
1
|
919
|
|
|
‡a
socialpathwayannotationextensionsofthesystemsbiologymetabolicmodellingassistant
‡A
Social pathway annotation: extensions of the systems biology metabolic modelling assistant
‡9
1
|
919
|
|
|
‡a
sodiumdependent50serinetransportinplasmamembranevesiclesisolatedfromehrlichcellsby2phasecompartmentation
‡A
Sodium-dependent L-serine transport in plasma membrane vesicles isolated from Ehrlich cells by two-phase compartmentation
‡9
1
|
919
|
|
|
‡a
spectroscopicanalysisofrecombinantrathistidinedecarboxylase
‡A
Spectroscopic analysis of recombinant rat histidine decarboxylase
‡9
1
|
919
|
|
|
‡a
structuralperspectiveonthedirectinhibitionmechanismofegcgonmammalianhistidinedecarboxylaseanddopadecarboxylase
‡A
Structural perspective on the direct inhibition mechanism of EGCG on mammalian histidine decarboxylase and DOPA decarboxylase
‡9
1
|
919
|
|
|
‡a
studyofpuupehenoneandrelatedcompoundsasinhibitorsofangiogenesis
‡A
Study of puupehenone and related compounds as inhibitors of angiogenesis
‡9
1
|
919
|
|
|
‡a
subcellulardistributionofadeninenucleotidesin2ehrlichcelllinesmetabolizingglucose
‡A
Subcellular distribution of adenine nucleotides in two Ehrlich cell lines metabolizing glucose
‡9
1
|
919
|
|
|
‡a
synthesisandantiangiogenicactivityofnewsilybingalloylesters
‡A
Synthesis and antiangiogenic activity of new silybin galloyl esters
‡9
1
|
919
|
|
|
‡a
synthesisandantitumoractivityevaluationofcompoundsbasedontoluquinol
‡A
Synthesis and Antitumor Activity Evaluation of Compounds Based on Toluquinol
‡9
1
|
919
|
|
|
‡a
systemsbiologyformolecularlifesciencesanditsimpactinbiomedicine
‡A
Systems biology for molecular life sciences and its impact in biomedicine
‡9
1
|
919
|
|
|
‡a
systemsbiologymetabolicmodelingassistantanontologybasedtoolfortheintegrationofmetabolicdatainkineticmodeling
‡A
Systems biology metabolic modeling assistant: an ontology-based tool for the integration of metabolic data in kinetic modeling.
‡9
1
|
919
|
|
|
‡a
antiangiogenic8epipuupehedionebehavesasapotentialantileukaemiccompoundagainsthl60cells
‡A
The anti-angiogenic 8-epipuupehedione behaves as a potential anti-leukaemic compound against HL-60 cells
‡9
1
|
919
|
|
|
‡a
antiangiogeniccompoundaeroplysinin1inducesapoptosisinendothelialcellsbyactivatingthemitochondrialpathway
‡A
The antiangiogenic compound aeroplysinin-1 induces apoptosis in endothelial cells by activating the mitochondrial pathway.
‡9
1
|
919
|
|
|
‡a
brominatedcompoundaeroplysinin1inhibitsproliferationandtheexpressionofkeyproinflammatorymoleculesinhumanendothelialandmonocytecells
‡A
The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cells
‡9
1
|
919
|
|
|
‡a
marinefungalmetabolitead0157inhibitsangiogenesisbytargetingtheaktsignalingpathway
‡A
The marine fungal metabolite, AD0157, inhibits angiogenesis by targeting the Akt signaling pathway
‡9
1
|
919
|
|
|
‡a
mediterraneandietarichsourceofangiopreventivecompoundsincancer
‡A
The Mediterranean Diet, a Rich Source of Angiopreventive Compounds in Cancer
‡9
1
|
919
|
|
|
‡a
nonianthraquinonedamnacanthalisamultikinaseinhibitorwithpotentantiangiogeniceffects
‡A
The noni anthraquinone damnacanthal is a multi-kinase inhibitor with potent anti-angiogenic effects
‡9
1
|
919
|
|
|
‡a
pestregionscontaining100terminiofmammalianornithinedecarboxylaseandhistidinedecarboxylaseplaydifferentrolesinproteindegradation
‡A
The pest regions containing C-termini of mammalian ornithine decarboxylase and histidine decarboxylase play different roles in protein degradation
‡9
1
|
919
|
|
|
‡a
pursuitofcreativityinbiology
‡A
The pursuit of creativity in biology
‡9
1
|
919
|
|
|
‡a
roleoffructose26bisphosphateinglycolyticoscillationsinextractsandcellsofsaccharomycescerevisiae
‡A
The role of fructose 2,6-bisphosphate in glycolytic oscillations in extracts and cells of Saccharomyces cerevisiae
‡9
1
|
919
|
|
|
‡a
stard4subfamilyofsteroidogenicacuteregulatoryrelatedlipidtransfer
‡A
The StarD4 subfamily of steroidogenic acute regulatory-related lipid transfer
‡9
1
|
919
|
|
|
‡a
stard4subfamilyofsteroidogenicacuteregulatoryrelatedlipidtransferstartdomainproteinsnewplayersincholesterolmetabolism
‡A
The StarD4 subfamily of steroidogenic acute regulatory-related lipid transfer (START) domain proteins: new players in cholesterol metabolism
‡9
1
|
919
|
|
|
‡a
usefulnessofpostgenomicstoolsforcharacterizationoftheaminecrosstalkinmammaliancells
‡A
The usefulness of post-genomics tools for characterization of the amine cross-talk in mammalian cells.
‡9
1
|
919
|
|
|
‡a
toluquinolamarinefungusmetaboliteisanewangiosuppresorthatinterfereswiththeaktpathway
‡A
Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes with the Akt pathway.
‡9
1
|
919
|
|
|
‡a
topologytinkeringandevolutionofthehumantranscriptionfactornetwork
‡A
Topology, tinkering and evolution of the human transcription factor network.
‡9
1
|
919
|
|
|
‡a
transmembraneferricyanidereductaseactivityinehrlichascitestumorcells
‡A
Transmembrane ferricyanide reductase activity in Ehrlich ascites tumor cells
‡9
1
|
919
|
|
|
‡a
2phasesofferricyanidereductaseactivityinehrlichcellplasmamembranes
‡A
Two phases of ferricyanide reductase activity in Ehrlich cell plasma membranes
‡9
1
|
919
|
|
|
‡a
whatisknownonangiogenesisrelatedrarediseasesasystematicreviewofliterature
‡A
What is known on angiogenesis-related rare diseases? A systematic review of literature.
‡9
1
|
919
|
|
|
‡a
whenmetabolismmeetstopologyreconcilingmetaboliteandreactionnetworks
‡A
When metabolism meets topology: Reconciling metabolite and reaction networks.
‡9
1
|
919
|
|
|
‡a
+aeroplysinin1modulatestheredoxbalanceofendothelialcells
‡A
(+)-Aeroplysinin-1 Modulates the Redox Balance of Endothelial Cells
‡9
1
|
919
|
|
|
‡a
4methylumbelliferoneinhibitsangiogenesisinvitroandinvivo
‡A
4-methylumbelliferone inhibits angiogenesis in vitro and in vivo
‡9
1
|
919
|
|
|
‡a
5synthesismetabolismandreleaseofhistamine
‡A
5. Synthesis, metabolism and release of histamine
‡9
1
|
919
|
|
|
‡a
combinedmodelofhepaticpolyamineandsulfuraminoacidmetabolismtoanalyzesadenosylmethionineavailability
‡A
A combined model of hepatic polyamine and sulfur amino acid metabolism to analyze S-adenosyl methionine availability
‡9
1
|
919
|
|
|
‡a
comparativestudyoftheeffectsofgenisteinand2methoxyestradiolontheproteolyticbalanceandtumourcellproliferation
‡A
A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation.
‡9
1
|
919
|
|
|
‡a
novelhomogenousassayfortopoisomerase2actionandinhibition
‡A
A novel homogenous assay for topoisomerase II action and inhibition
‡9
1
|
919
|
|
|
‡a
plasmamembraneredoxsysteminhumanretinoblastomacells
‡A
A plasma membrane redox system in human retinoblastoma cells
‡9
1
|
919
|
|
|
‡a
problemcasebasedlearningapproachasanusefultoolforstudyingglycogenmetabolismanditsregulation
‡A
A problem-/case-based learning approach as an useful tool for studying glycogen metabolism and its regulation
‡9
1
|
919
|
|
|
‡a
reevaluationoffumagillinselectivitytowardsendothelialcells
‡A
A re-evaluation of fumagillin selectivity towards endothelial cells
‡9
1
|
919
|
|
|
‡a
reevaluationofthemitogeniceffectofserotoninonvascularendothelialcells
‡A
A re-evaluation of the mitogenic effect of serotonin on vascular endothelial cells
‡9
1
|
919
|
|
|
‡a
advancesintheknowledgeofthemolecularbiologyofglioblastomaanditsimpactinpatientdiagnosisstratificationandtreatment
‡A
Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment
‡9
1
|
919
|
|
|
‡a
alteredornithinemetabolismintumorbearingmice
‡A
Altered ornithine metabolism in tumor-bearing mice
‡9
1
|
919
|
|
|
‡a
experimentonapoptosisinducedbypolyamineadductsproducedinthepresenceofserumamineoxidase
‡A
An experiment on apoptosis induced by polyamine adducts produced in the presence of serum amine oxidase
‡9
1
|
919
|
|
|
‡a
invitroevaluationoftheeffectsofhomocysteinethiolactoneonkeystepsofangiogenesisandtumorinvasion
‡A
An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion.
‡9
1
|
919
|
|
|
‡a
analysisofmammalianhistidinedecarboxylasedimerizationinterfacerevealsanelectrostatichotspotimportantforcatalyticsitetopologyandfunction
‡A
Analysis of Mammalian Histidine Decarboxylase Dimerization Interface Reveals an Electrostatic Hotspot Important for Catalytic Site Topology and Function
‡9
1
|
919
|
|
|
‡a
antiangiogeniceffectsofhomocysteineonculturedendothelialcells
‡A
Anti-angiogenic effects of homocysteine on cultured endothelial cells
‡9
1
|
919
|
|
|
‡a
antiangiogenicpropertiesofcarnosolandcarnosicacid2majordietarycompoundsfromrosemary
‡A
Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary.
‡9
1
|
919
|
|
|
‡a
antiangiogenicactivityofaeroplysinin1abrominatedcompoundisolatedfromamarinesponge
‡A
Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge
‡9
1
|
919
|
|
|
‡a
ascorbicacidiscytotoxicforpediatrictumorcellsculturedinvitro
‡A
Ascorbic acid is cytotoxic for pediatric tumor cells cultured in vitro
‡9
1
|
919
|
|
|
‡a
biogenicaminesandpolyaminessimilarbiochemistryfordifferentphysiologicalmissionsandbiomedicalapplications
‡A
Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications
‡9
1
|
919
|
|
|
‡a
challengesofantiangiogeniccancertherapytrialsanderrorsandrenewedhope
‡A
Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope
‡9
1
|
919
|
|
|
‡a
characterizationofplasmamembraneredoxactivityfromehrlichcells
‡A
Characterization of plasma membrane redox activity from Ehrlich cells
‡9
1
|
919
|
|
|
‡a
characterizationofspermineuptakebyehrlichtumourcellsinculture
‡A
Characterization of spermine uptake by Ehrlich tumour cells in culture.
‡9
1
|
919
|
|
|
‡a
chlorpheniramineinhibitsthesynthesisofornithinedecarboxylaseandtheproliferationofhumanbreastcancercelllines
‡A
Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines
‡9
1
|
919
|
|
|
‡a
comparisonoftheantiangiogenicpotentialofhydroxytyrosoland5derivatives
‡A
Comparison of the anti-angiogenic potential of hydroxytyrosol and five derivatives
‡9
1
|
919
|
|
|
‡a
contributionbyhosttissuestocirculatingglutamineinmiceinoculatedwithehrlichascitestumorcells
‡A
Contribution by host tissues to circulating glutamine in mice inoculated with Ehrlich ascites tumor cells
‡9
1
|
919
|
|
|
‡a
correctionantiangiogenicandantiinflammatorypropertiesofkahweolacoffeediterpene
‡A
Correction: Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene.
‡9
1
|
919
|
|
|
‡a
correctionglobalanalysisofthehumanpathophenotypicsimilaritygenenetworkmergesdiseasemodulecomponents
‡A
Correction: Global Analysis of the Human Pathophenotypic Similarity Gene Network Merges Disease Module Components
‡9
1
|
919
|
|
|
‡a
damnacanthalanonianthraquinoneinhibits100metandisapotentantitumorcompoundagainsthepg2humanhepatocellularcarcinomacells
‡A
Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells
‡9
1
|
919
|
|
|
‡a
damnacanthalinhibitsigereceptormediatedactivationofmastcells
‡A
Damnacanthal inhibits IgE receptor-mediated activation of mast cells
‡9
1
|
919
|
|
|
‡a
danthronananthraquinoneisolatedfromamarinefungusisanewinhibitorofangiogenesisexhibitinginterestingantitumorandantioxidantproperties
‡A
Danthron, an Anthraquinone Isolated from a Marine Fungus, Is a New Inhibitor of Angiogenesis Exhibiting Interesting Antitumor and Antioxidant Properties
‡9
1
|
919
|
|
|
‡a
determinationofacampdependentproteinkinasephosphorylationsiteinthe100terminalregionofhumanendothelialactinbindingprotein
‡A
Determination of a cAMP-dependent protein kinase phosphorylation site in the C-terminal region of human endothelial actin-binding protein
‡9
1
|
919
|
|
|
‡a
developmentofanexpressionmacroarrayforaminemetabolismrelatedgenes
‡A
Development of an expression macroarray for amine metabolism-related genes.
‡9
1
|
919
|
|
|
‡a
diaminesinterferewiththetransportof50ornithineinehrlichcellplasmamembranevesicles
‡A
Diamines interfere with the transport of L-ornithine in Ehrlich-cell plasma-membrane vesicles
‡9
1
|
919
|
|
|
‡a
dietaryproteinsandangiogenesis
‡A
Dietary proteins and angiogenesis
‡9
1
|
919
|
|
|
‡a
dimethylfumarateinhibitsangiogenesisinvitroandinvivoapossibleroleforitsantipsoriaticeffect
‡A
Dimethylfumarate inhibits angiogenesis in vitro and in vivo: a possible role for its antipsoriatic effect?
‡9
1
|
919
|
|
|
‡a
dnachlorpheniramineinteractionstudiedbyspectroscopictechniques
‡A
DNA-chlorpheniramine interaction studied by spectroscopic techniques.
‡9
1
|
919
|
|
|
‡a
donotsayevernevermoretheinsandoutsofantiangiogenictherapies
‡A
Do not say ever never more: the ins and outs of antiangiogenic therapies
‡9
1
|
919
|
|
|
‡a
dtdanantiinflammatoryditriazineinhibitsangiogenesisinvitroandinvivo
‡A
DTD, an anti-inflammatory ditriazine, inhibits angiogenesis in vitro and in vivo
‡9
1
|
919
|
|
|
‡a
dualroleofplasmamembraneelectrontransportsystemsindefense
‡A
Dual role of plasma membrane electron transport systems in defense
‡9
1
|
919
|
|
|
‡a
earlysystemiceffectsonthehepaticmitochondriaoftumourbearingmice
‡A
Early systemic effects on the hepatic mitochondria of tumour bearing mice
‡9
1
|
919
|
|
|
‡a
effectofpalmitateacetateandglucoseonglutaminemetabolisminehrlichascitestumorcells
‡A
Effect of palmitate, acetate and glucose on glutamine metabolism in Ehrlich ascites tumor cells
‡9
1
|
919
|
|
|
‡a
effectsofgenisteinand2methoxyestradiolonmatrixmetalloproteinasesandtheirinhibitorssecretedbyehrlichascitestumorcells
‡A
Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells
‡9
1
|
919
|
|
|
‡a
effectsofphorbolesteranddexamethasonetreatmentonhistidinedecarboxylaseandornithinedecarboxylaseinbasophiliccells
‡A
Effects of phorbol ester and dexamethasone treatment on histidine decarboxylase and ornithine decarboxylase in basophilic cells
‡9
1
|
919
|
|
|
‡a
effectsofproteinkinase100andphosphoproteinphosphatasemodulatorsonehrlichcellplasmamembraneredoxsystemactivity
‡A
Effects of protein kinase C and phosphoprotein phosphatase modulators on Ehrlich cell plasma membrane redox system activity
‡9
1
|
919
|
|
|
‡a
effectsofursolicacidondifferentstepsoftheangiogenicprocess
‡A
Effects of ursolic acid on different steps of the angiogenic process
‡9
1
|
919
|
|
|
‡a
ehrlichcellplasmamembraneredoxsystemismodulatedthroughsignaltransductionpathwaysinvolvingcgmpandca2+as2messengers
‡A
Ehrlich cell plasma membrane redox system is modulated through signal transduction pathways involving cGMP and Ca2+ as second messengers
‡9
1
|
919
|
|
|
‡a
epigallocatechin3gallateinterfereswithmastcelladhesivenessmigrationanditspotentialtorecruitmonocytes
‡A
(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes.
‡9
1
|
919
|
|
|
‡a
epigallocatechingallatereduceshumanmonocytemobilityandadhesioninvitro
‡A
Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro
‡9
1
|
919
|
|
|
‡a
erstressincreasesstard5expressionbystabilizingitsmrnaandleadstorelocalizationofitsproteinfromthenucleustothemembranes
‡A
ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes.
‡9
1
|
919
|
|
|
‡a
evaluationoftheantiangiogeniceffectofaloeemodin
‡A
Evaluation of the anti-angiogenic effect of aloe-emodin
‡9
1
|
919
|
|
|
‡a
evidenceofanintracellulardissipativestructure
‡A
Evidence of an intracellular dissipative structure
‡9
1
|
919
|
|
|
‡a
experimentalevidenceforstructureactivityfeaturesincommonbetweenmammalianhistidinedecarboxylaseandornithinedecarboxylase
‡A
Experimental evidence for structure-activity features in common between mammalian histidine decarboxylase and ornithine decarboxylase
‡9
1
|
919
|
|
|
‡a
exploringandchallengingthenetworkofangiogenesis
‡A
Exploring and challenging the network of angiogenesis.
‡9
1
|
919
|
|
|
‡a
fasentindiminishesendothelialcellproliferationdifferentiationandinvasioninaglucosemetabolismindependentmanner
‡A
Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner
‡9
1
|
919
|
|
|
‡a
1stepsincomputationalsystemsbiologyapracticalsessioninmetabolicmodelingandsimulation
‡A
First steps in computational systems biology: A practical session in metabolic modeling and simulation.
‡9
1
|
919
|
|
|
‡a
fouriertransformramanstudyofthestructuralspecificitiesontheinteractionbetweendnaandbiogenicpolyamines
‡A
Fourier transform Raman study of the structural specificities on the interaction between DNA and biogenic polyamines
‡9
1
|
919
|
|
|
‡a
functionalreconstitutionofehrlichcellplasmamembraneferricyanidereductase
‡A
Functional reconstitution of Ehrlich cell plasma membrane ferricyanide reductase
‡9
1
|
919
|
|
|
‡a
geneticbasisofhyperhomocysteinemia
‡A
Genetic basis of hyperhomocysteinemia.
‡9
1
|
919
|
|
|
‡a
glucosefavorslipidanabolicmetabolismintheinvasivebreastcancercelllinemdamb231
‡A
Glucose Favors Lipid Anabolic Metabolism in the Invasive Breast Cancer Cell Line MDA-MB-231
‡9
1
|
919
|
|
|
‡a
glutamineandglucoseasenergysubstratesforehrlichascitestumourcells
‡A
Glutamine and glucose as energy substrates for Ehrlich ascites tumour cells
‡9
1
|
919
|
|
|
‡a
glutaminetransportbyvesiclesisolatedfromtumourcellmitochondrialinnermembrane
‡A
Glutamine transport by vesicles isolated from tumour-cell mitochondrial inner membrane
‡9
1
|
919
|
|
|
‡a
glycolysisandglutaminolysisinperifusedehrlichascitestumourcells
‡A
Glycolysis and glutaminolysis in perifused Ehrlich ascites tumour cells
‡9
1
|
919
|
|
|
‡a
greenteaepigallocatechin3gallateisaninhibitorofmammalianhistidinedecarboxylase
‡A
Green tea epigallocatechin-3-gallate is an inhibitor of mammalian histidine decarboxylase
‡9
1
|
919
|
|
|
‡a
histaminepolyaminesandcancer
‡A
Histamine, polyamines, and cancer.
‡9
1
|
919
|
|
|
‡a
homocysteineanemergentcardiovascularriskfactor
‡A
Homocysteine: an emergent cardiovascular risk factor?
‡9
1
|
919
|
|
|
‡a
homocysteineinhibitstheproliferationandinvasivepotentialofht1080humanfibrosarcomacells
‡A
Homocysteine inhibits the proliferation and invasive potential of HT-1080 human fibrosarcoma cells
‡9
1
|
919
|
|
|
‡a
homocysteineisapotentinhibitorofhumantumorcellgelatinases
‡A
Homocysteine is a potent inhibitor of human tumor cell gelatinases
‡9
1
|
919
|
|
|
‡a
homocysteineisapotentmodulatorofplasmamembraneelectrontransportsystems
‡A
Homocysteine is a potent modulator of plasma membrane electron transport systems.
‡9
1
|
919
|
|
|
‡a
johnswortisanewinhibitorofangiogenesistargetingseveralkeystepsoftheprocess
‡A
John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process
‡9
1
|
919
|
|
|
‡a
hyperhomocysteinemiaandocclusivevasculardiseaseanemergentroleforfibroblastgrowthfactor2
‡A
Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.
‡9
1
|
919
|
|
|
‡a
hypericininthedarkinhibitskeystepsofangiogenesisinvitro
‡A
Hypericin in the dark inhibits key steps of angiogenesis in vitro
‡9
1
|
919
|
|
|
‡a
ib05204adichloropyridodithienotriazineinhibitsangiogenesisinvitroandinvivo
‡A
IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo
‡9
1
|
919
|
|
|
‡a
identificationofazn
‡A
Identification of a Zn
‡9
1
|
919
|
|
|
‡a
identificationofazn2+sensitivecomponentofehrlichcellplasmamembraneredoxsystembychapsagarosepolyacrylamideelectrophoresisandinsitustainingofactivity
‡A
Identification of a Zn(2+)-sensitive component of Ehrlich cell plasma membrane redox system by CHAPS-agarose-polyacrylamide electrophoresis and in situ staining of activity
‡9
1
|
919
|
|
|
‡a
insilicoanalysisofargininecatabolismasasourceofnitricoxideorpolyaminesinendothelialcells
‡A
In silico analysis of arginine catabolism as a source of nitric oxide or polyamines in endothelial cells.
‡9
1
|
919
|
|
|
‡a
invitrostudyofproteolyticdegradationofrathistidinedecarboxylase
‡A
In vitro study of proteolytic degradation of rat histidine decarboxylase
‡9
1
|
919
|
|
|
‡a
inorganicphosphateandenergychargecompartmentationinehrlichascitestumourcellsinthepresenceofglucoseandorglutamine
‡A
Inorganic phosphate and energy charge compartmentation in Ehrlich ascites tumour cells in the presence of glucose and/or glutamine
‡9
1
|
919
|
|
|
‡a
insightsontheantitumoreffectsofkahweolonhumanbreastcancerdecreasedsurvivalandincreasedproductionofreactiveoxygenspeciesandcytotoxicity
‡A
Insights on the antitumor effects of kahweol on human breast cancer: decreased survival and increased production of reactive oxygen species and cytotoxicity
‡9
1
|
919
|
|
|
‡a
interchangeofaminoacidsbetweentumorandhost
‡A
Interchange of amino acids between tumor and host
‡9
1
|
919
|
|
|
‡a
involvementofessentialhistidineresidue
‡A
Involvement of essential histidine residue
‡9
1
|
919
|
|
|
‡a
involvementofessentialhistidineresiduesintheactivityofehrlichcellplasmamembranenadhferricyanideoxidoreductase
‡A
Involvement of essential histidine residue(s) in the activity of Ehrlich cell plasma membrane NADH-ferricyanide oxidoreductase
‡9
1
|
919
|
|
|
‡a
kpathintegrationofmetabolicpathwaylinkeddata
‡A
kpath: integration of metabolic pathway linked data
‡9
1
|
919
|
|
|
‡a
alaninetransportbysystemsaandascinplasmamembranevesiclesisolatedfromehrlichcells
‡A
L-alanine transport by systems A and ASC in plasma membrane vesicles isolated from Ehrlich cells
‡9
1
|
919
|
|
|
‡a
glutaminetransportinnativevesiclesisolatedfromehrlichascitestumorcellmembranes
‡A
L-glutamine transport in native vesicles isolated from Ehrlich ascites tumor cell membranes.
‡9
1
|
919
|
|
|
‡a
localchangesinthecatalyticsiteofmammalianhistidinedecarboxylasecanaffectitsglobalconformationandstability
‡A
Local changes in the catalytic site of mammalian histidine decarboxylase can affect its global conformation and stability
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
BNC|981058523332706706
|
996
|
|
|
‡2
BNC|981058517344806706
|
996
|
|
|
‡2
ISNI|0000000054685608
|
996
|
|
|
‡2
J9U|987007314699305171
|
996
|
|
|
‡2
J9U|987007452731105171
|
996
|
|
|
‡2
BNCHL|10000000000000000024744
|
996
|
|
|
‡2
BNC|981058530042206706
|
996
|
|
|
‡2
LC|ns2016002565
|
996
|
|
|
‡2
NTA|130320498
|
996
|
|
|
‡2
ISNI|0000000034554061
|
996
|
|
|
‡2
PTBNP|1177789
|
996
|
|
|
‡2
BNCHL|10000000000000000222670
|
996
|
|
|
‡2
NTA|133605140
|
996
|
|
|
‡2
NUKAT|n 2011050048
|
996
|
|
|
‡2
LC|no2013114177
|
996
|
|
|
‡2
BNE|XX1182854
|
996
|
|
|
‡2
LC|n 97849211
|
996
|
|
|
‡2
BNE|XX4877693
|
996
|
|
|
‡2
BNC|981058517185206706
|
996
|
|
|
‡2
NTA|12617296X
|
996
|
|
|
‡2
DNB|1222548429
|
996
|
|
|
‡2
LC|n 80151623
|
996
|
|
|
‡2
BNE|XX1130349
|
996
|
|
|
‡2
DNB|1057258172
|
996
|
|
|
‡2
ISNI|0000000030525183
|
996
|
|
|
‡2
BNF|14571805
|
996
|
|
|
‡2
BNE|XX983808
|
996
|
|
|
‡2
DNB|1249506611
|
996
|
|
|
‡2
SUDOC|079074030
|
996
|
|
|
‡2
PTBNP|89816
|
996
|
|
|
‡2
ISNI|0000000080788926
|
996
|
|
|
‡2
RERO|A017107485
|
996
|
|
|
‡2
ISNI|0000000493149479
|
996
|
|
|
‡2
LC|n 98110377
|
996
|
|
|
‡2
LC|no 00038675
|
996
|
|
|
‡2
ISNI|0000000041214364
|
996
|
|
|
‡2
LC|no2020119541
|
996
|
|
|
‡2
DNB|1158991517
|
996
|
|
|
‡2
BNCHL|10000000000000000059653
|
996
|
|
|
‡2
SUDOC|068911335
|
996
|
|
|
‡2
LC|no2017167822
|
996
|
|
|
‡2
BNC|981058530034106706
|
996
|
|
|
‡2
LC|no2023044200
|
996
|
|
|
‡2
LC|n 99048932
|
996
|
|
|
‡2
SUDOC|030305330
|
996
|
|
|
‡2
ISNI|0000000060907828
|
996
|
|
|
‡2
BNF|12912479
|
996
|
|
|
‡2
BNE|XX1115269
|
996
|
|
|
‡2
ISNI|0000000420179757
|
996
|
|
|
‡2
NII|DA08965146
|
996
|
|
|
‡2
PLWABN|9810534711605606
|
996
|
|
|
‡2
DNB|172641705
|
996
|
|
|
‡2
BNC|981058517712706706
|
996
|
|
|
‡2
BNC|981058526508006706
|
996
|
|
|
‡2
DNB|1056461470
|
996
|
|
|
‡2
BNE|XX1361833
|
996
|
|
|
‡2
LC|n 2006016647
|
996
|
|
|
‡2
ISNI|0000000052359454
|
996
|
|
|
‡2
BNF|12276842
|
996
|
|
|
‡2
BNC|981061103926906706
|
996
|
|
|
‡2
BAV|495_215254
|
996
|
|
|
‡2
LC|n 97105716
|
996
|
|
|
‡2
CAOONL|ncf13671983
|
996
|
|
|
‡2
BNF|12174877
|
996
|
|
|
‡2
RERO|A020433544
|
996
|
|
|
‡2
LC|n 80151377
|
996
|
|
|
‡2
BNE|XX830197
|
996
|
|
|
‡2
LC|no2014023491
|
996
|
|
|
‡2
CAOONL|ncf10706686
|
996
|
|
|
‡2
BNE|XX938375
|
996
|
|
|
‡2
BNE|XX907145
|
996
|
|
|
‡2
NII|DA06685535
|
996
|
|
|
‡2
BNE|XX868997
|
996
|
|
|
‡2
DNB|1172044562
|
996
|
|
|
‡2
BNE|XX1298500
|
996
|
|
|
‡2
NKC|ola2015868956
|
996
|
|
|
‡2
DNB|1341109259
|
996
|
|
|
‡2
ISNI|0000000510799052
|
996
|
|
|
‡2
LC|nr2002013405
|
996
|
|
|
‡2
LC|no2012159026
|
996
|
|
|
‡2
LC|no2015164024
|
996
|
|
|
‡2
BNE|XX1476895
|
996
|
|
|
‡2
DNB|1122071205
|
996
|
|
|
‡2
J9U|987007586233405171
|
996
|
|
|
‡2
BNE|XX1036975
|
996
|
|
|
‡2
ISNI|000000006817848X
|
996
|
|
|
‡2
ISNI|0000000066331567
|
996
|
|
|
‡2
LC|ns2014000311
|
996
|
|
|
‡2
BLBNB|000301561
|
996
|
|
|
‡2
BNF|10643477
|
996
|
|
|
‡2
BNE|XX1789563
|
996
|
|
|
‡2
BNE|XX4609829
|
996
|
|
|
‡2
BNE|XX5751305
|
996
|
|
|
‡2
BNC|981058614295006706
|
996
|
|
|
‡2
SUDOC|050710494
|
996
|
|
|
‡2
LC|n 95023653
|
996
|
|
|
‡2
LC|no2010057715
|
996
|
|
|
‡2
DNB|1057099996
|
996
|
|
|
‡2
ISNI|0000000107978587
|
996
|
|
|
‡2
ISNI|0000000081435604
|
996
|
|
|
‡2
BNCHL|10000000000000000165649
|
996
|
|
|
‡2
BNE|XX1371777
|
996
|
|
|
‡2
LC|no 99015953
|
996
|
|
|
‡2
LC|nr 96006121
|
996
|
|
|
‡2
LC|n 85252769
|
996
|
|
|
‡2
J9U|987007361549805171
|
996
|
|
|
‡2
ISNI|0000000060257925
|
996
|
|
|
‡2
LC|no2014113721
|
996
|
|
|
‡2
ISNI|0000000060747983
|
996
|
|
|
‡2
ISNI|0000000034545819
|
996
|
|
|
‡2
BNE|XX913365
|
996
|
|
|
‡2
RERO|A003579203
|
996
|
|
|
‡2
ISNI|0000000427894067
|
996
|
|
|
‡2
LC|no2011004528
|
996
|
|
|
‡2
LC|no2021064709
|
996
|
|
|
‡2
CAOONL|ncf10681290
|
996
|
|
|
‡2
LC|no2011008882
|
996
|
|
|
‡2
BNCHL|10000000000000000128457
|
996
|
|
|
‡2
LC|no2020120391
|
996
|
|
|
‡2
ISNI|0000000111547253
|
996
|
|
|
‡2
LC|no 90019123
|
996
|
|
|
‡2
LC|no2021029215
|
996
|
|
|
‡2
DNB|1157387179
|
996
|
|
|
‡2
NKC|pna2016915907
|
996
|
|
|
‡2
BNC|981058615864306706
|
996
|
|
|
‡2
SUDOC|254591892
|
996
|
|
|
‡2
PTBNP|89569
|
996
|
|
|
‡2
BNE|XX1792267
|
996
|
|
|
‡2
LC|n 2019052030
|
996
|
|
|
‡2
LC|nr2002012538
|
996
|
|
|
‡2
B2Q|0001513222
|
996
|
|
|
‡2
ISNI|000000011608346X
|
996
|
|
|
‡2
DNB|119757532
|
996
|
|
|
‡2
LC|no2005036744
|
996
|
|
|
‡2
ISNI|0000000024510364
|
996
|
|
|
‡2
J9U|987007512634805171
|
996
|
|
|
‡2
ARBABN|000056211
|
996
|
|
|
‡2
BNF|17701056
|
996
|
|
|
‡2
ISNI|000000004264477X
|
996
|
|
|
‡2
BNF|13554327
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|